Cash Flow Sartorius Stedim Biotech SA Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
375.00
227.00
401.00
1,130.00
646.00
460.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-25.00
251.00
190.00
-351.00
-152.00
-47.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
538.00
638.00
629.00
602.00
693.00
414.00
Cash Flow from Investing Activities
-397.00
-340.00
-2,810.00
-998.00
-465.00
-651.00
Cash Flow from Financing Activities
-389.00
261.00
2,190.00
271.00
-69.00
267.00
Net Cash Inflow / Outflow
-252.00
562.00
9.00
-116.00
163.00
31.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-4.00
2.00
0.00
8.00
4.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in EUR Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Sartorius Stedim Biotech SA
Figures in Million
consolidated Cash Flow Results
Change(EUR)
Change(%)
Profit Before Tax
375.4
3195
-2,820.00
-88.25%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-25.4
-446
421.00
94.30%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
538.6
5291
-4,753.00
-89.82%
Cash Flow from Investing Activities
-397.7
-2636
2,239.00
84.91%
Cash Flow from Financing Activities
-389.2
-971
582.00
59.92%
Net Cash Inflow / Outflow
-252.8
1293
-1,545.00
-119.55%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-4.5
-391
387.00
98.85%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is -15.61% vs 1.35% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
538.60
638.20
-15.61%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
